The DOI matches its Crossref record; 73 of the 73 references it cites were found in a registry or an index.
IL-2, Regulatory T Cells, and Tolerance
Abstract
IL-2 is a potent T cell growth factor that for many years was assumed to amplify lymphocyte responses in vivo. Accordingly, IL-2 has been used clinically to enhance T cell immunity in patients with AIDS or cancer, and blocking Abs to the IL-2R are used to inhibit T cell responses against transplanted tissues. It was later shown in mice that, unexpectedly, disruption of the IL-2 pathway results in lymphoid hyperplasia and autoimmunity rather than immune deficiency, indicating that the major physiological function of IL-2 is to limit rather than enhance T cell responses. This apparent paradox has recently been resolved with the discovery that IL-2 is critical for the development and peripheral expansion of CD4+CD25+ regulatory T cells, which promote self-tolerance by suppressing T cell responses in vivo. Our new understanding of IL-2 biology prompts a re-evaluation of how best to clinically manipulate this important immunoregulatory pathway.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Van Parijs, L., Refaeli, Y., Lord, J. D., Nelson, B. H., Abbas, A. K., & Baltimore, D. (1999) · Immunity · doi:10.1016/s1074-7613(00)80103-x · Cited by 423
Self-citationRetractedFoxp3 programs the development and function of CD4+CD25+ regulatory T cells
Fontenot, J. D., Gavin, M. A., & Rudensky, A. Y. (2003) · Nature Immunology · doi:10.1038/ni904 · Cited by 7,745
An essential role for Scurfin in CD4+CD25+ T regulatory cells
Khattri, R., Cox, T., Yasayko, S.-A., & Ramsdell, F. (2003) · Nature Immunology · doi:10.1038/ni909 · Cited by 2,856
Interleukin-2: Inception, Impact, and Implications
Smith, K. A. (1988) · Science · doi:10.1126/science.3131876 · Cited by 2,153
CD4+CD25high Regulatory Cells in Human Peripheral Blood
Baecher-Allan, C., Brown, J. A., Freeman, G. J., & Hafler, D. A. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.3.1245 · Cited by 1,859
Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene
Sadlack, B., Merz, H., Schorle, H., Schimpl, A., Feller, A. C., & Horak, I. (1993) · Cell · doi:10.1016/0092-8674(93)80067-o · Cited by 1,744
Stimulation of CD25(+)CD4(+) regulatory T cells through GITR breaks immunological self-tolerance
Shimizu, J., Yamazaki, S., Takahashi, T., Ishida, Y., & Sakaguchi, S. (2002) · Nature Immunology · doi:10.1038/ni759 · Cited by 1,729
Yee, C., Thompson, J. A., Byrd, D., Riddell, S. R., Roche, P., Celis, E., & Greenberg, P. D. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.242600099 · Cited by 1,206
Interleukin-2 receptor α chain regulates the size and content of the peripheral lymphoid compartment
Willerford, D. M., Chen, J., Ferry, J. A., Davidson, L., Ma, A., & Alt, F. W. (1995) · Immunity · doi:10.1016/1074-7613(95)90180-9 · Cited by 1,080
lnterleukin-2 programs mouse αβ T lymphocytes for apoptosis
Lenardo, M. J. (1991) · Nature · doi:10.1038/353858a0 · Cited by 1,012
Development and function of T cells in mice rendered interleukin-2 deficient by gene targeting
Schorle, H., Holtschke, T., Hünig, T., Schimpl, A., & Horak, I. (1991) · Nature · doi:10.1038/352621a0 · Cited by 879
Deregulated T Cell Activation and Autoimmunity in Mice Lacking Interleukin-2 Receptor β
Suzuki, H., Kündig, T. M., Furlonger, C., Wakeham, A., Timms, E., Matsuyama, T., Schmits, R., Simard, J. J. L., Ohashi, P. S., Griesser, H., et al. (1995) · Science · doi:10.1126/science.7770771 · Cited by 871
Control of Homeostasis of CD8 + Memory T Cells by Opposing Cytokines
Ku, C. C., Murakami, M., Sakamoto, A., Kappler, J., & Marrack, P. (2000) · Science · doi:10.1126/science.288.5466.675 · Cited by 816
CD4 Regulatory T Cells Prevent Lethal Autoimmunity in IL-2Rβ-Deficient Mice
Malek, T. R., Yu, A., Vincek, V., Scibelli, P., & Kong, L. (2002) · Immunity · doi:10.1016/s1074-7613(02)00367-9 · Cited by 779
Activation‐induced cell death in T cells
Green, D. R., Droin, N., & Pinkoski, M. (2003) · Immunological Reviews · doi:10.1034/j.1600-065x.2003.00051.x · Cited by 647
Homeostasis and anergy of CD4+CD25+ suppressor T cells in vivo
Gavin, M. A., Clarke, S. R., Negrou, E., Gallegos, A., & Rudensky, A. (2002) · Nature Immunology · doi:10.1038/ni743 · Cited by 640
Biochemical Mechanisms of IL-2–Regulated Fas-Mediated T Cell Apoptosis
Refaeli, Y., Van Parijs, L., London, C. A., Tschopp, J., & Abbas, A. K. (1998) · Immunity · doi:10.1016/s1074-7613(00)80566-x · Cited by 639
Interleukin 2 Signaling Is Required for CD4+ Regulatory T Cell Function
Furtado, G. C., de Lafaille, M. A. C., Kutchukhidze, N., & Lafaille, J. J. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020190 · Cited by 625
Inducible IL-2 production by dendritic cells revealed by global gene expression analysis
Granucci, F., Vizzardelli, C., Pavelka, N., Feau, S., Persico, M., Virzi, E., Rescigno, M., Moro, G., & Ricciardi-Castagnoli, P. (2001) · Nature Immunology · doi:10.1038/ni0901-882 · Cited by 520
Biology of the Interleukin-2 Receptor
Nelson, B. H., & Willerford, D. M. (1998) · Advances in Immunology · doi:10.1016/s0065-2776(08)60386-7 · Cited by 475
Self-citationAlmeida, A. R. M., Legrand, N., Papiernik, M., & Freitas, A. A. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.9.4850 · Cited by 468
Immune Responses in Interleukin-2-Deficient Mice
Kündig, T. M., Schorle, H., Bachmann, M. F., Hengartner, H., Zinkernagel, R. M., & Horak, I. (1993) · Science · doi:10.1126/science.8235625 · Cited by 462
The Regulatory T Cell Family: Distinct Subsets and their Interrelations
Jonuleit, H., & Schmitt, E. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.12.6323 · Cited by 436
Papiernik, M. (1998) · International Immunology · doi:10.1093/intimm/10.4.371 · Cited by 434
Sadlack, B., Löhler, J., Schorle, H., Klebb, G., Haber, H., Sickel, E., Noelle, R. J., & Horak, I. (1995) · European Journal of Immunology · doi:10.1002/eji.1830251111 · Cited by 423
Interferon γ Is Required for Activation-induced Death of T Lymphocytes
Refaeli, Y., Van Parijs, L., Alexander, S. I., & Abbas, A. K. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020666 · Cited by 417
Regulatory T cells under scrutiny
François Bach, J. (2003) · Nature Reviews Immunology · doi:10.1038/nri1026 · Cited by 413
Human immune disorder arising from mutation of the α chain of the interleukin-2 receptor
Sharfe, N., Dadi, H. K., Shahar, M., & Roifman, C. M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.7.3168 · Cited by 409
Therapeutic use of IL-2 to enhance antiviral T-cell responses in vivo
Blattman, J. N., Grayson, J. M., Wherry, E. J., Kaech, S. M., Smith, K. A., & Ahmed, R. (2003) · Nature Medicine · doi:10.1038/nm866 · Cited by 396
Both CD4+CD25+ and CD4+CD25− Regulatory Cells Mediate Dominant Transplantation Tolerance
Graca, L., Thompson, S., Lin, C.-Y., Adams, E., Cobbold, S. P., & Waldmann, H. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.11.5558 · Cited by 362
Suzuki, H., Duncan, G. S., Takimoto, H., & Mak, T. W. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.3.499 · Cited by 351
Stephens, L. A., & Mason, D. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.6.3105 · Cited by 311
Kuniyasu, Y., Takahashi, T., Itoh, M., Shimizu, J., Toda, G., & Sakaguchi, S. (2000) · International Immunology · doi:10.1093/intimm/12.8.1145 · Cited by 290
Homeostatic T Cell Proliferation
Surh, C. D., & Sprent, J. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.4.f9 · Cited by 277
Kneitz, B., Herrmann, T., Yonehara, S., & Schimpl, A. (1995) · European Journal of Immunology · doi:10.1002/eji.1830250925 · Cited by 229
Khoruts, A., Mondino, A., Pape, K. A., Reiner, S. L., & Jenkins, M. K. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.2.225 · Cited by 211
Antov, A., Yang, L., Vig, M., Baltimore, D., & Van Parijs, L. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.7.3435 · Cited by 204
Induction and prevention of colonic inflammation in IL-2-deficient mice
Ehrhardt, R. O., Lúdvíksson, B. R., Gray, B., Neurath, M., & Strober, W. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.2.566 · Cited by 201
IL-2 knockout recipient mice reject islet cell allografts
Steiger, J., Nickerson, P. W., Steurer, W., Moscovitch-Lopatin, M., & Strom, T. B. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.1.489 · Cited by 198
CD4+CD8- T cells are the effector cells in disease pathogenesis in the scurfy ( sf ) mouse.
Blair, P. J., Bultman, S. J., Haas, J. C., Rouse, B. T., Wilkinson, J. E., & Godfrey, V. L. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.153.8.3764 · Cited by 185
Van Parijs, L., Biuckians, A., Ibragimov, A., Alt, F. W., Willerford, D. M., & Abbas, A. K. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.8.3738 · Cited by 184
Molecular regulation of interleukin‐2 expression by CD28 co‐stimulation and anergy
Powell, J. D., Ragheb, J. A., Kitagawa‐Sakakida, S., & Schwartz, R. H. (1998) · Immunological Reviews · doi:10.1111/j.1600-065x.1998.tb01246.x · Cited by 180
Contractor, N. V., Bassiri, H., Reya, T., Park, A. Y., Baumgart, D. C., Wasik, M. A., Emerson, S. G., & Carding, S. R. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.1.385 · Cited by 180
Cousens, L. P., Orange, J. S., & Biron, C. A. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.12.5690 · Cited by 176
Wolf, M., Schimpl, A., & Hünig, T. (2001) · European Journal of Immunology · Cited by 175
Dai, Z., Konieczny, B. T., Baddoura, F. K., & Lakkis, F. G. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.4.1659 · Cited by 174
Shimizu, K., Fields, R. C., Giedlin, M., & Mulé, J. J. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.5.2268 · Cited by 172
Cytokines in T-cell development
Carding, S. R., Hayday, A. C., & Bottomly, K. (1991) · Immunology Today · doi:10.1016/0167-5699(91)90037-t · Cited by 161
Malek, T. R., Porter, B. O., Codias, E. K., Scibelli, P., & Yu, A. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.6.2905 · Cited by 149
T cells, but not B cells, are required for bowel inflammation in interleukin 2-deficient mice.
Ma, A. I., Datta, M., Margosian, E., Chen, J., & Horak, I. D. (1995) · The Journal of Experimental Medicine · doi:10.1084/jem.182.5.1567 · Cited by 147
Krämer, S., Schimpl, A., & Hünig, T. (1995) · The Journal of Experimental Medicine · doi:10.1084/jem.182.6.1769 · Cited by 142
Evidence that CD4+, but not CD8+ T cells are responsible for murine interleukin‐2‐deficient colitis
Simpson, S. J., Mizoguchi, E., Allen, D., Bhan, A. K., & Terhorst, C. (1995) · European Journal of Immunology · doi:10.1002/eji.1830250932 · Cited by 135
Zheng, L., Trageser, C., Willerford, D. M., & Lenardo, M. J. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.2.763 · Cited by 134
Advances in interleukin 2 receptor targeted treatment
Morris, J. C., & Waldmann, T. A. (2000) · Annals of the Rheumatic Diseases · doi:10.1136/ard.59.suppl_1.i109 · Cited by 131
Essential Role for IL-2 in the Regulation of Antiviral Extralymphoid CD8 T Cell Responses
D’Souza, W. N., Schluns, K. S., Masopust, D., & Lefrançois, L. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.11.5566 · Cited by 131
Loss of Tolerance and Autoimmunity Affecting Multiple Organs in STAT5A/5B -Deficient Mice
Snow, J. W., Abraham, N., Ma, M. C., HERNDIER, B. G., Pastuszak, A. W., & Goldsmith, M. A. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.10.5042 · Cited by 131
Cheng, L. E., Öhlén, C., Nelson, B. H., & Greenberg, P. D. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.052676899 · Cited by 128
Self-citationCurrent status of interleukin-2 therapy for metastatic renal cell carcinoma and metastatic melanoma.
Dutcher, J. P. (2002) · PubMed · Cited by 107
The Pleiotropic Functions of Interleukin 15
Ma, A. I., Boone, D. L., & Lodolce, J. P. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.5.753 · Cited by 103
Suzuki, H., Zhou, Y., Kato, M., Mak, T. W., & Nakashima, I. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.11.1561 · Cited by 102
Dai, Z., Arakelov, A., Wagener, M. E., et al. (1999) · PubMed · Cited by 84
Regulation of T Cell Homeostasis by Heparan Sulfate-Bound IL-2
Wrenshall, L. E., & Platt, J. L. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.7.3793 · Cited by 77
Induction of interleukin 2 receptor beta chain expression by self-recognition in the thymus.
Hanke, T., Mitnacht, R., Boyd, R. L., & Hünig, T. (1994) · The Journal of Experimental Medicine · doi:10.1084/jem.180.5.1629 · Cited by 67
Sereti, I., Martinez-Wilson, H. F., Metcalf, J. A., et al. (2002) · Blood · doi:10.1182/blood.v100.6.2159 · Cited by 66
Opposing Effects of IL-2 in Tumor Immunotherapy: Promoting CD8 T Cell Growth and Inducing Apoptosis
Shrikant, P. A., & Mescher, M. F. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.4.1753 · Cited by 65
Fujii, H., Ogasawara, K., Otsuka, H., Suzuki, M., Yamamura, K., Yokochi, T., Miyazaki, T., Suzuki, H., Mak, T. W., Taki, S., et al. (1998) · The EMBO Journal · doi:10.1093/emboj/17.22.6551 · Cited by 61
Krämer, S., Mamalaki, C., Horak, I. D., Schimpl, A., Kioussis, D., & Hünig, T. (1994) · European Journal of Immunology · doi:10.1002/eji.1830241009 · Cited by 61
Regulation of Lymphoid Homeostasis by IL-2 Receptor Signals In Vivo
Leung, D. T. M., Morefield, S., & Willerford, D. M. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.7.3527 · Cited by 56
Porter, B. O., & Malek, T. R. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.11.5906 · Cited by 49
Porter, B. O., & Malek, T. R. (1999) · PubMed · Cited by 46
Suzuki, H. (1997) · International Immunology · doi:10.1093/intimm/9.9.1367 · Cited by 45
Propagation and Control of T Cell Responses by Heparan Sulfate-Bound IL-2
Wrenshall, L. E., Platt, J. L., Stevens, E. T., Wight, T. N., & Miller, J. D. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.11.5470 · Cited by 35
Spontaneous Expression of Interleukin‐2 In Vivo in Specific Tissues of Young Mice
Yang-Snyder, J., & Rothenberg, E. V. (1997) · Journal of Immunology Research · doi:10.1155/1998/12421 · Cited by 32
Cited by
A function for interleukin 2 in Foxp3-expressing regulatory T cells
Fontenot, J. D., Rasmussen, J. P., Gavin, M. A., & Rudensky, A. Y. (2005) · Nature Immunology · doi:10.1038/ni1263 · Cited by 1,819
Interleukin-2 and Regulatory T Cells in Graft-versus-Host Disease
Koreth, J., Matsuoka, K.-I., Kim, H. T., McDonough, S. M., Bindra, B., Alyea, E. P., Armand, P., Cutler, C., Ho, V. T., Treister, N. S., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1108188 · Cited by 1,119
Inflammation and the pathogenesis of atrial fibrillation
Hu, Y.-F., Chen, Y.-J., Lin, Y.-J., & Chen, S.-A. (2015) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2015.2 · Cited by 1,089
Ziegler, S. F. (2006) · Annual Review of Immunology · doi:10.1146/annurev.immunol.24.021605.090547 · Cited by 922
Cytokine patterns in patients with cancer: a systematic review
Lippitz, B. E. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70582-x · Cited by 905
Metadata
- Authors
- Nelson, B. H.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2004-04-01
- Volume
- 172
- Issue
- 7
- Pages
- 3983-3988
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1921702206
- Cited by
- 556
- References
- 73
- FWCI
- 12.46
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.